发明名称 |
HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES |
摘要 |
We have constructed bispecific antibody engaging molecules which have one arm that specifically engages a tumor cell which expresses the human EGFRvIII mutant protein on its surface, and a second arm that specifically engages T cell activation ligand CD3. The engaging molecules are highly cytotoxic and antigen-specific. These are promising therapeutic agents. |
申请公布号 |
US2015132306(A1) |
申请公布日期 |
2015.05.14 |
申请号 |
US201314406161 |
申请日期 |
2013.06.07 |
申请人 |
DUKE UNIVERSITY ;THE UNITED STATES GOVERMENT AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES |
发明人 |
Bigner Darell;Kuan Chien-Tsun;Sampson John;Choi Bryan;Pastan Ira H. |
分类号 |
C07K16/28;C12N15/11 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A bispecific polypeptide, comprising:
a first single chain human variable region which binds to EGFRvIII, and comprises segments encoded by SEQ ID NO: 2 and 3; in series with a second single chain human variable region which binds to T cell activation ligand CD3 and comprises segments encoded by SEQ ID NO: 5 and 6; |
地址 |
Durham NC US |